Altimmune reported additional positive Phase 2 RECLAIM results for its investigational 1:1 glucagon/GLP-1 dual agonist in alcohol use disorder. The data were pr

BWB News TV • 2026-11-09 17:51 UTC • By Billy Odell Tucker-Robinson

Altimmune reported additional positive Phase 2 RECLAIM results for its investigational 1:1 glucagon/GLP-1 dual agonist in alcohol use disorder. The data were presented at AASLD as the company prepares to report Q3 2026 results on Nov. 12.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly